ETON PHARMACEUTICALS INC (ETON) Fundamental Analysis & Valuation

NASDAQ:ETON • US29772L1089

Current stock price

18.93 USD
-0.09 (-0.47%)
At close:
18.93 USD
0 (0%)
After Hours:

This ETON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ETON Profitability Analysis

1.1 Basic Checks

  • In the past year ETON has reported negative net income.
  • In the past year ETON had a positive cash flow from operations.
  • ETON had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ETON reported negative operating cash flow in multiple years.
ETON Yearly Net Income VS EBIT VS OCF VS FCFETON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • With a decent Return On Assets value of -6.39%, ETON is doing good in the industry, outperforming 72.40% of the companies in the same industry.
  • ETON has a better Return On Equity (-28.89%) than 62.50% of its industry peers.
Industry RankSector Rank
ROA -6.39%
ROE -28.89%
ROIC N/A
ROA(3y)-14.67%
ROA(5y)-31.48%
ROE(3y)-30.22%
ROE(5y)-56.08%
ROIC(3y)N/A
ROIC(5y)N/A
ETON Yearly ROA, ROE, ROICETON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Gross Margin of ETON (51.36%) is better than 66.15% of its industry peers.
  • ETON's Gross Margin has improved in the last couple of years.
  • ETON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.67%
GM growth 5Y2.47%
ETON Yearly Profit, Operating, Gross MarginsETON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ETON Health Analysis

2.1 Basic Checks

  • ETON does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ETON has more shares outstanding
  • Compared to 5 years ago, ETON has more shares outstanding
  • ETON has a worse debt/assets ratio than last year.
ETON Yearly Shares OutstandingETON Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ETON Yearly Total Debt VS Total AssetsETON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.14 indicates that ETON is not in any danger for bankruptcy at the moment.
  • ETON has a better Altman-Z score (3.14) than 69.27% of its industry peers.
  • ETON has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as ETON would need 2.36 years to pay back of all of its debts.
  • The Debt to FCF ratio of ETON (2.36) is better than 93.75% of its industry peers.
  • A Debt/Equity ratio of 1.31 is on the high side and indicates that ETON has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.31, ETON is not doing good in the industry: 73.44% of the companies in the same industry are doing better.
  • Even though the debt/equity ratio score it not favorable for ETON, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 2.36
Altman-Z 3.14
ROIC/WACCN/A
WACC9.34%
ETON Yearly LT Debt VS Equity VS FCFETON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • ETON has a Current Ratio of 1.63. This is a normal value and indicates that ETON is financially healthy and should not expect problems in meeting its short term obligations.
  • ETON has a worse Current ratio (1.63) than 66.67% of its industry peers.
  • ETON has a Quick Ratio of 1.25. This is a normal value and indicates that ETON is financially healthy and should not expect problems in meeting its short term obligations.
  • ETON's Quick ratio of 1.25 is on the low side compared to the rest of the industry. ETON is outperformed by 69.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.25
ETON Yearly Current Assets VS Current LiabilitesETON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ETON Growth Analysis

3.1 Past

  • ETON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.86%, which is quite impressive.
  • The Revenue has grown by 102.77% in the past year. This is a very strong growth!
  • Measured over the past years, ETON shows a very strong growth in Revenue. The Revenue has been growing by 109.79% on average per year.
EPS 1Y (TTM)42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-333.33%
Revenue 1Y (TTM)102.77%
Revenue growth 3Y21.35%
Revenue growth 5Y109.79%
Sales Q2Q%117.54%

3.2 Future

  • Based on estimates for the next years, ETON will show a very strong growth in Earnings Per Share. The EPS will grow by 82.58% on average per year.
  • Based on estimates for the next years, ETON will show a very strong growth in Revenue. The Revenue will grow by 41.27% on average per year.
EPS Next Y19.86%
EPS Next 2Y192.94%
EPS Next 3Y134.56%
EPS Next 5Y82.58%
Revenue Next Year109.09%
Revenue Next 2Y64.69%
Revenue Next 3Y53.88%
Revenue Next 5Y41.27%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ETON Yearly Revenue VS EstimatesETON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ETON Yearly EPS VS EstimatesETON Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ETON Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ETON. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 20.54 indicates a rather expensive valuation of ETON.
  • 79.17% of the companies in the same industry are more expensive than ETON, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of ETON to the average of the S&P500 Index (23.83), we can say ETON is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 20.54
ETON Price Earnings VS Forward Price EarningsETON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

  • ETON's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ETON is cheaper than 75.00% of the companies in the same industry.
  • ETON's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ETON is cheaper than 78.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.38
EV/EBITDA 445.59
ETON Per share dataETON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ETON's earnings are expected to grow with 134.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y192.94%
EPS Next 3Y134.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ETON Dividend Analysis

5.1 Amount

  • No dividends for ETON!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ETON Fundamentals: All Metrics, Ratios and Statistics

ETON PHARMACEUTICALS INC

NASDAQ:ETON (3/13/2026, 8:23:19 PM)

After market: 18.93 0 (0%)

18.93

-0.09 (-0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners59.87%
Inst Owner Change-10.43%
Ins Owners4.39%
Ins Owner Change0.12%
Market Cap507.70M
Revenue(TTM)70.32M
Net Income(TTM)-6.68M
Analysts82.22
Price Target30.6 (61.65%)
Short Float %8.22%
Short Ratio8.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-171.8%
Min EPS beat(2)-176.25%
Max EPS beat(2)-167.35%
EPS beat(4)1
Avg EPS beat(4)-200.94%
Min EPS beat(4)-488.82%
Max EPS beat(4)28.68%
EPS beat(8)3
Avg EPS beat(8)-70.46%
EPS beat(12)7
Avg EPS beat(12)8.52%
EPS beat(16)8
Avg EPS beat(16)-25.56%
Revenue beat(2)2
Avg Revenue beat(2)9.29%
Min Revenue beat(2)7.55%
Max Revenue beat(2)11.04%
Revenue beat(4)4
Avg Revenue beat(4)9.75%
Min Revenue beat(4)7.55%
Max Revenue beat(4)11.97%
Revenue beat(8)6
Avg Revenue beat(8)4.4%
Revenue beat(12)9
Avg Revenue beat(12)10.96%
Revenue beat(16)10
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-6.9%
EPS NQ rev (3m)-42.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-73.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.54
P/S 7.22
P/FCF 39.38
P/OCF 23.82
P/B 21.95
P/tB N/A
EV/EBITDA 445.59
EPS(TTM)-0.12
EYN/A
EPS(NY)0.92
Fwd EY4.87%
FCF(TTM)0.48
FCFY2.54%
OCF(TTM)0.79
OCFY4.2%
SpS2.62
BVpS0.86
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.39%
ROE -28.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.36%
FCFM 18.34%
ROA(3y)-14.67%
ROA(5y)-31.48%
ROE(3y)-30.22%
ROE(5y)-56.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.67%
GM growth 5Y2.47%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 2.36
Debt/EBITDA 27.16
Cap/Depr 248.85%
Cap/Sales 11.97%
Interest Coverage N/A
Cash Conversion 1906.08%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.25
Altman-Z 3.14
F-Score4
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)372.49%
Cap/Depr(5y)366.77%
Cap/Sales(3y)13.75%
Cap/Sales(5y)36.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-333.33%
EPS Next Y19.86%
EPS Next 2Y192.94%
EPS Next 3Y134.56%
EPS Next 5Y82.58%
Revenue 1Y (TTM)102.77%
Revenue growth 3Y21.35%
Revenue growth 5Y109.79%
Sales Q2Q%117.54%
Revenue Next Year109.09%
Revenue Next 2Y64.69%
Revenue Next 3Y53.88%
Revenue Next 5Y41.27%
EBIT growth 1Y56.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year622.77%
EBIT Next 3Y170.16%
EBIT Next 5YN/A
FCF growth 1Y39.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y129.88%
OCF growth 3YN/A
OCF growth 5YN/A

ETON PHARMACEUTICALS INC / ETON Fundamental Analysis FAQ

What is the fundamental rating for ETON stock?

ChartMill assigns a fundamental rating of 4 / 10 to ETON.


Can you provide the valuation status for ETON PHARMACEUTICALS INC?

ChartMill assigns a valuation rating of 4 / 10 to ETON PHARMACEUTICALS INC (ETON). This can be considered as Fairly Valued.


What is the profitability of ETON stock?

ETON PHARMACEUTICALS INC (ETON) has a profitability rating of 3 / 10.


Can you provide the financial health for ETON stock?

The financial health rating of ETON PHARMACEUTICALS INC (ETON) is 5 / 10.